Multiple-dose Pharmacokinetics of a Novel, Synthetic Trioxane-antimalarial Compound 97/78 in Rats Using Lc-ms/ms Method
نویسندگان
چکیده
*Corresponding Author: Dr. S.K. Singh, Senior Principal Scientist and In-charge, Pharmacokinetics & Metabolism Division, Central Drug Research Institute, Lucknow, India. 3122 MULTIPLE-DOSE PHARMACOKINETICS OF A NOVEL, SYNTHETIC TRIOXANE-ANTIMALARIAL COMPOUND 97/78 IN RATS USING LC-MS/MS METHOD Rajendra Pratap Singh, S Sabarinath, Hari Narayan Kushwaha, Nagsen Gautam, Ram Chandra Gupta and Shio Kumar Singh* Pharmacokinetics and Metabolism Division, Central Drug Research Institute, Lucknow, India.
منابع مشابه
Pharmacokinetic Study and Bioavailability of a Novel Synthetic Trioxane Antimalarial Compound 97/63 in Rats
Single dose pharmacokinetics study of 97/63 (IND191710, 2004), a trioxane antimalarial developed by Central Drug Research Institute, Lucknow, India, was studied in rats following intravenous and oral administration. Serum samples were analysed by HPLC-UV assay. Separation was achieved on a RP-18 column attached with a guard using acetonitrile : phosphate buffer (70 : 30% v/v) with UV detector a...
متن کاملSingle Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug
Background. CDRI 97/78 has shown efficacy in animal models of falciparum malaria. The present study is the first in-human phase I trial in healthy volunteers. Methods. The study was conducted in 50 healthy volunteers in a single, ascending dose, randomized, placebo-controlled, double blind design. The dose ranges evaluated were from 80 mg to 700 mg. Volunteers were assessed for clinical, bioche...
متن کاملEvaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry.
The microdosing strategy allows for early assessment of human pharmacokinetics of new chemical entities using more limited safety assessment requirements than those requisite for a conventional phase I program. The current choice for evaluating microdosing is accelerator mass spectrometry (AMS) due to its ultrasensitivity for detecting radiotracers. However, the AMS technique is still expensive...
متن کاملFirst assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone.
In preclinical studies, artemisone (BAY 44-9585), a new artemisinin derivative, was shown to possess enhanced efficacy over artesunate, and it does not possess the neurotoxicity characteristic of the current artemisinins. In a phase I program with double-blind, randomized, placebo-controlled, single and multiple ascending oral-dose studies, we evaluated the safety, tolerability, pharmacokinetic...
متن کاملA Report on Finding a New Peptide Aldehyde from Cyanobacterium Nostoc sp. Bahar M by LC-MS and Marfey’s Analysis
Background: Cyanobacteria have a worldwide distribution in the terrestrial habitats, occurring predominantly on the surface of the soils, stones, rocks, and trees, practically in moist, neutral or alkaline aeries. The unique natural and bioactive compounds from cyanobacteria with various biological activities and an extensive range of chemical classes have a significant capabil...
متن کامل